HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in ratsQie Shi, Erfan Wei, Zhibin Liu et al.|Neuroscience|2015Cited by 62